Methodist Cancer Center, Houston, Texas
Also known as: Ahmed Osama Gaber, MD | Ashley Holder, MD | Breast Medical Oncologist, Methodist Cancer Center, Houston, Texas | Clinical Trial Network | David Baskin MD | Houston Methodist | Houston Methodist Cancer Center | Houston Methodist Centers of Performing Arts Medicine | Houston Methodist Gastroenterology Associates | Houston Methodist Gastroenterology Clinical Research Foundation, Houston, Texas | Houston Methodist Hosptial | Houston Methodist Neal Cancer Center | Houston Methodist Neurological Institute | HOUSTON METHODIST NEUROLOGICAL INSTITUTE | Houston Methodist Physicians Organization | Jenny C. Chang, MD | Jorge G. Darcourt | METHODIST | Methodist Cardiovascular Surgery Associates | Methodist Dallas Medical Center | Methodist DeBakey Heart Center. | Methodist DeBakey Heart Center, Houston TX, USA | Methodist Hospital - Texas Transplant Institute | METHODIST HOSP RES | Methodist Neurological Institute | Methodist Neurological Institute, Houston | Rose Khavari, M.D. | Stanley H. Appel, MD | The Methodist Hospital System | William Ondo, MD
Highest phase reached
Phase 4
Timeline
1910s
- Jan 1, 1919
Methodist Cancer Center, Houston, Texas— Founded
2020s
- Jul 9, 2021
ammonia n-13— Marketing Organization
Drugs by trial phase (194 distinct, 189 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (90 own, 0 via acquisition)
Phase 1 (72 own, 0 via acquisition)
- cmv-specific t-cells
- atezolizumab
- honokiol
- ny-eso-1, magea4, prame, survivin and ssx - specific t cells
- autologous ebv specific cytotoxic t lymphocytes
- olaparib
- cd40 ligand-expressing tumor cells
- brentuximab vedotin
- car t cells
- lenalidomide
- cd40 ligand
- oxycodone
- denileukin diftitox
- eb-vst cells
- glycar t cells
- +57 more
Indications
Studied for
- Acute Lung Injury
- Acute Pain
- Adenocarcinoma
- Adenoviridae Infections
- Adrenal Insufficiency
- Amyotrophic Lateral Sclerosis
- Anemia
- Anemia, Aplastic
- Anemia, Sickle Cell
- Aneurysm
- Anus Neoplasms
- Aortic Aneurysm
- Aortic Diseases
- Astrocytoma
- Atrial Fibrillation
- Autoimmune Diseases
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cholecystolithiasis
- Cholelithiasis
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Coronavirus Infections
- Cytomegalovirus Infections
- Deafness
- Disease
- DNA Repair-Deficiency Disorders
- Emergencies
- Epstein-Barr Virus Infections
- Fanconi Anemia
- Fanconi Syndrome
- Gallstones
- Glioblastoma
- Glioma
- Hearing Loss
- Heart Failure
- Hematologic Diseases
- Hemoglobinopathies
- Hepatoblastoma
- Histiocytosis
- Histiocytosis, Langerhans-Cell
- Hodgkin Disease
- Hypotension
- Hypotension, Orthostatic
- Infections
- Intervertebral Disc Degeneration
- Intestinal Obstruction
- Irritable Bowel Syndrome
- Joint Diseases
- Kidney Diseases
- Kidney Failure, Chronic
- Leiomyosarcoma
- Leukemia
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Diseases
- Lung Neoplasms
- Lymphohistiocytosis, Hemophagocytic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphoproliferative Disorders
- Melanoma
- Mental Disorders
- Metabolic Diseases
- Motor Neuron Disease
- Multiple Myeloma
- Multiple Sclerosis
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Myocardial Ischemia
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Neoplasms by Site
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Neuroblastoma
- Osteosarcoma
- Pancreatic Neoplasms
- Paraproteinemias
- Parkinson Disease
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
Marketed drugs (3)
Recent trials (50)
- NCT07042685OfficialPhase 2Aug 31, 2025
- NCT07060001OfficialPhase 2Jul 31, 2025
- NCT06887218OfficialPhase 2May 8, 2025
- NCT06833866OfficialPhase 1Dec 4, 2024
- NCT06566443OfficialPhase 1Aug 31, 2024
- NCT06536413OfficialPhase 1/Phase 2Jul 29, 2024
- NCT05660083Overall official - principal investigatorPhase 2Jan 1, 2023
- NCT04614363Overall official - principal investigatorPhase 1/Phase 2Oct 13, 2020
- NCT04614363Lead sponsorPhase 1/Phase 2Oct 13, 2020
- NCT04614363Reponsible party - principal investigatorPhase 1/Phase 2Oct 13, 2020
- NCT04401410CollaboratorPhase 1Jul 30, 2020
- NCT04494724Overall official - principal investigatorPhase 2Jul 13, 2020
- NCT04494724Lead sponsorPhase 2Jul 13, 2020
- NCT04447924Overall official - principal investigatorN/AJun 22, 2020
- NCT04288726CollaboratorPhase 1Jun 1, 2020
Details
- Founded
- Houston, TX, US Jan 1, 1919
- Last known activity
- Oct 10, 2025
Notes
Couldn't find a specific date om 1924 --- Pre-folding founded info: 1924-01-01 Houston Texas United States https://www.methodisthealthsystem.org/about/history/ ---